<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="117792">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02073669</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-13-0668-DS-CTIL</org_study_id>
    <nct_id>NCT02073669</nct_id>
  </id_info>
  <brief_title>Latent Tuberculosis in Second Generation Immigrants From High Risk Countries Compare to Low-risk Young Israeli Adults</brief_title>
  <official_title>Better Identification of Latent Tuberculosis Infection Among Israeli Young Adults by Comparison Skin Tests and Interferon Gamma Releasing Assays (IGRA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tel Aviv Lung Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of study is to evaluate the prevalence of latent TB in second generation immigrants
      from countries with high incidence of tuberculosis (above 20 of 100,000) compare to the
      control native Israelis without a family member who was born in a country with high
      incidence of tuberculosis. Using study questionnaire IGRA and tuberculin skin test the
      investigators expect that the second generation immigrants group will have more positive
      IGRA test than the control native group.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Interferon gamma release assay ( IGRA)</measure>
    <time_frame>Up to 3 months after tuberculin skin test</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Latent Tuberculosis</condition>
  <arm_group>
    <arm_group_label>Second generation immigrants from high TB incidence countries</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Answering the study Questionnaire and blood sampling for Interferon gamma release assay (IGRA).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Native Israelis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Answering the study Questionnaire and blood sampling for Interferon gamma release assay (IGRA).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Answering the study Questionnaire and blood sampling for Interferon gamma release assay (IGRA)</intervention_name>
    <arm_group_label>Second generation immigrants from high TB incidence countries</arm_group_label>
    <arm_group_label>Native Israelis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-25

          -  Men and women

          -  Second generation immigrants from countries with high incidence of tuberculosis
             (above 20 of 100,000).

          -  Native Israelis without a family member who was born in a country with high incidence
             of tuberculosis.

        Exclusion Criteria:

          -  Prior contact with a tuberculosis patient

          -  Working (more than a month) in high risk setting such as health care workers, working
             with immigrants from countries with high incidence of tuberculosis.

          -  HIV infection and any immunodeficiency condition.

          -  Recent live-virus vaccination

          -  Acute infectious disease

          -  Prior serious reaction to tuberculin skin test

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Dekel Shlomi, M.D.</last_name>
    <phone>972-3-5302339</phone>
    <email>dekel.shlomi@sheba.health.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 26, 2014</lastchanged_date>
  <firstreceived_date>February 25, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>latent tuberculosis</keyword>
  <keyword>tuberculin skin test</keyword>
  <keyword>Interferon gamma release assay</keyword>
  <keyword>immigration</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Tuberculosis</mesh_term>
    <mesh_term>Latent Tuberculosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Interferon-gamma</mesh_term>
    <mesh_term>Interferons</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
